Pharmaceuticals Company Investment Opportunity in Colombo, Sri Lanka
ISO 90001 & ISO 14001 certified company setting up saline manufacturing facility in Sri Lanka.
This transaction has concluded.
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Pharmaceuticals |
| Locations | Colombo |
| Local Time | 5:49 AM Asia / Colombo |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
10 million
for
51.0%
stake
(Native Currency: LKR 3,000,000,000)
Reason: To set up the saline manufacturing facility.
Includes physical assets worth
USD
3 million
Interested to connect with advisors
Documents
Company Profile
(278.4 KB)
Certificate of Incorporation
(3.3 MB)
TIN Certificate
(121.9 KB)
Valuation Report 1
(455.6 KB)
Valuation Report 2
(439.8 KB)
Valuation Report 3
(441.7 KB)
Valuation Report 4
(395.7 KB)
Valuation Report 5
(393.7 KB)
Business Overview
- Setting up an Intravenous Solutions (Saline) Manufacturing facility in Sri Lanka. Work is already in progress.
- We will be exporting majority of the production.
- The plant will be equipped with latest machinery from Italy, Germany and Japan with WHO GMP, PICS GMP, EU and US FDA standards.
- Plant will have a capacity of making 53 Million bottles of 500 ML, 20 Million bottles of 250 ML, 20 Million bottles of 100 ML and 200 Million of small volume IV solutions per annum.
- We are in negotiation to supply our products to following countries - Indonesia, Cambodia, Thailand, Myanmar, Philippines, Qatar, Zambia and some parts of India.
- Total investment for this project is USD $ 27 Million and we have already invested USD $ 8 Million in the project.
- It will take 15 months to set up the plant and 6 months for the facility qualification. The facility is expected to start commercial operations in the next 6 months.
- We will be exporting majority of the production.
- The plant will be equipped with latest machinery from Italy, Germany and Japan with WHO GMP, PICS GMP, EU and US FDA standards.
- Plant will have a capacity of making 53 Million bottles of 500 ML, 20 Million bottles of 250 ML, 20 Million bottles of 100 ML and 200 Million of small volume IV solutions per annum.
- We are in negotiation to supply our products to following countries - Indonesia, Cambodia, Thailand, Myanmar, Philippines, Qatar, Zambia and some parts of India.
- Total investment for this project is USD $ 27 Million and we have already invested USD $ 8 Million in the project.
- It will take 15 months to set up the plant and 6 months for the facility qualification. The facility is expected to start commercial operations in the next 6 months.
Products & Services Overview
All large and small volume Intravenous solutions.
Facilities Overview
25,000 m2 own land area with built up area of 7,000 m2 with proposed single storey building.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysExecutive Director, New Delhi, Financial Consultant connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
